Canadian Adaptive Platform Trial of Treatments for COVID in Community Settings (CanTreatCOVID): protocol for a randomised controlled adaptive platform trial of treatments for acute SARS-CoV-2 infection in community settings.
Hosseini B, Condon A, da Costa BR, Daley P, Greiver M, Jüni P, Lee TC, McBrien K, McDonald EG, Murthy S, Selby P, Andrew M, Aubrey-Bassler K, Barber D, Barrett B, Butler CC, Crampton N, Dahrouge S, Damji A, Fowler R, Garies S, Hudon C, Hulme J, Isenor J, Jenkins DJA, Lall R, LeBlanc A, Leong C, Little P, Lofters A, Logsetty S, Lother S, Lussier MT, Maclaren L, Mangin D, Marshall EG, Marshall JC, McCracken R, Moineddin R, Orava B, Paquette JS, Park JJH, Persaud N, Rac VE, Ramsden VR, Rayner J, Sanchez-Ramirez DC, Saxinger L, Shi H, Singer A, Spiwak R, Srivastava A, Sud A, Tarride JE, Telner D, Upshur REG, Walji S, Walsh R, Wilchesky M, Wong ST, Wood B, Zarychanski R, Zelek B, Keynan Y, Piszczek J, Warshafsky D, Pinto AD.
Hosseini B, et al.
BMJ Open. 2025 Aug 3;15(8):e097134. doi: 10.1136/bmjopen-2024-097134.
BMJ Open. 2025.
PMID: 40754325
Free PMC article.
INTRODUCTION: SARS-CoV-2 is now endemic and expected to remain a health threat, with new variants continuing to emerge and the potential for vaccines to become less effective. ...METHODS AND ANALYSIS: CanTreatCOVID is an open-label, individually randomised, m …
INTRODUCTION: SARS-CoV-2 is now endemic and expected to remain a health threat, with new variants continuing to emerge …